Candiduria
Conditions
Interventions
Retrospective cohort:None
Prospective Cohort:None
Sponsors
Huashan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Retrospective study section inclusion criteria: (1) Age >= 18 years old, gender unrestricted; (2) During the visit, simultaneously meet the following diagnostic criteria for candiduria: 1) At least two positive cultures of clean midstream urine, catheter drainage fluid, or urinary tract fistula drainage fluid with Candida >= 10^3 CFU/ml within one year prior to the visit; 2) At least one urine routine test with white blood cell count higher than the upper limit of normal within one week before and after the visit. (3) The patient's symptoms, signs, urinary tract-related medical history, and test results such as urine culture, urine routine, liver and kidney function can be traced in the hospital's medical history system during the visit for candiduria. (4) Obtained remote informed consent or met the requirements for exemption from informed consent. 2. Prospective study section inclusion criteria: (1) Age >= 18 years old, gender unrestricted; (2) The patient or the authorized representative can understand and sign the informed consent form; (3) Simultaneously meet the following diagnostic criteria for candiduria: 1) At least two positive cultures of clean midstream urine, catheter drainage fluid, or urinary tract fistula drainage fluid with Candida >= 10^3 CFU/ml within one year; 2) Urine routine test with white blood cell count higher than the upper limit of normal.
Exclusion criteria
Exclusion criteria: 1.Retrospective study: Exclusion criteria: (1) Not meeting the clinical and laboratory diagnostic criteria for the included diseases; (2) Those who refused to be enrolled in this clinical study. 2.Prospective study: (1) Does not meet the clinical and laboratory diagnostic criteria for the included disease; (2) Patients with concurrent pregnancy; (3) Those who do not agree to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence Rate;Treatment Efficacy Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Susceptibility Rate to Antifungals; | — |
Countries
China
Contacts
Public ContactXu Su
Huashan Hospital, Fudan University
Outcome results
None listed